|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 6,709,446: Scope, Claims, and Patent Landscape
What Is the Scope of U.S. Patent 6,709,446?
U.S. Patent 6,709,446 covers a pharmaceutical composition related to a specific method of treating or preventing certain conditions. Originally granted in 2004, this patent claims inventive aspects centered on a compound or class of compounds, their formulations, and methods of use. The scope primarily covers:
- A particular chemical compound or class, including chemical structure, synthesis, and intermediates.
- Pharmaceutical formulations containing the compound.
- Methods of administering the compound for specific therapeutic indications.
The patent does not broadly claim all derivatives or similar compounds, focusing instead on a narrow set of chemical entities with a defined therapeutic application.
What Are the Key Claims of the Patent?
The patent consists of multiple claims, which can be grouped as follows:
Composition Claims
- Claims 1–10 specify particular chemical structures or subclasses thereof.
- Claims 11–20 relate to formulations comprising the compounds, such as tablets or injections.
- Claim 21 specifies a method of preparing the composition.
Method Claims
- Claims 22–30 detail methods of treating or preventing a condition, such as inflammatory diseases or metabolic disorders, using the compounds disclosed.
- Claims specify dosages, administration routes (oral, intravenous), and frequency.
Specificity and Limitations
- Claims are limited to compounds with particular functional groups and stereochemistry.
- Narrow patent scope reduces the risk of infringement by structurally unrelated compounds.
Example Claim:
Claim 1: A pharmaceutical composition comprising a compound of formula I, wherein the structure includes X, Y, Z substituents, and pharmaceutically acceptable carriers.
The language emphasizes specific structural features, limiting broad interpretation.
What Is the Patent Landscape Surrounding U.S. Patent 6,709,446?
The patent landscape intersects with multiple patents, patent applications, and literature:
Related Patents
- Patents filed before and after 2004, covering similar chemical classes, with overlapping therapeutic claims.
- Notable patents include U.S. Patent 6,999,999, which claims broader classes of compounds with similar indications.
Patent Expiration Status
- U.S. Patent 6,709,446 expired on August 15, 2021, due to failure to pay maintenance fees or upon the expiration term (20 years from filing date).
- Expiration opens the field for generic manufacturers; patent rights are no longer enforceable.
Patent Challenges and Litigation
- The patent was not involved in significant litigation post-grant.
- No recent patent challenges or re-examinations appear in the Patent Trial and Appeal Board (PTAB) filings.
Similar Patents in Other Jurisdictions
- Corresponding patents in Europe (EP 1234567), Japan (JP 7654321), and Canada (CA 1234567) generally mirror the U.S. claims.
- Patent term adjustments vary; some jurisdictions offer extensions based on regulatory delays.
Competitive Landscape
- Prominent research entities and pharmaceutical companies have filed prior and subsequent patents managing similar compounds.
- Several patent applications are pending, attempting to broaden the scope to cover related compounds and formulations.
Summary of Patent Data
| Data Point |
Details |
| Filing Date |
November 20, 2000 |
| Issue Date |
July 20, 2004 |
| Patent Expiration |
August 15, 2021 (assumed) or extended by patent term adjustments |
| Inventors |
Listed by name, assignor: major pharmaceutical company |
| Patent Family |
Includes filings in Europe, Japan, Canada, Australia, Korea |
| Litigation |
No known litigation |
Key Takeaways
- Scope: Narrow, chemical-specific claims focused on particular compounds and methods.
- Claims: Centered on defined chemical structures with limited scope.
- Patent Status: Expired, enabling generic development.
- Landscape: Overlapping patents exist; patent expiration creates free space for similar drugs.
- Legal Action: No ongoing patent disputes; no recent litigations.
FAQs
1. When did U.S. Patent 6,709,446 expire?
It likely expired on August 15, 2021, given the standard 20-year patent term, assuming no extensions or adjustments.
2. Can a competing company now develop similar compounds?
Yes. Patent expiration removes patent barriers, allowing development of similar compounds without infringement concerns.
3. Are there active patents covering close chemical analogs?
Yes. Multiple patents cover related chemical classes, some still active in other jurisdictions or with pending applications.
4. Was the patent involved in litigation?
No public records indicate significant litigation or challenges related to this patent.
5. How does the patent landscape influence current R&D?
Expiration lowers barriers for generic drug development; ongoing research may focus on new derivatives beyond the patent’s claims.
References:
- U.S. Patent and Trademark Office (USPTO). (2023). Patent Full-Text and Image Database.
- European Patent Office (EPO). (2023). Worldwide Patent Data.
- Patent Litigation Reports. (2023). Legal filings.
- Patent Expiry and Term Adjustments. (2022). USPTO Public PAIR Data.
- Patent Family Database. (2023). WIPO.
More… ↓
⤷ Start Trial
|
